[(4-Chlorobutyl)sulfanyl]benzene → N-(3-{1-[4-(Phenylsulfanyl)butyl]-4-piperidinyl}phenyl)cyclopropanecarboxamide
반응식
Cl[CH2:2][CH2:3][CH2:4][CH2:5][S:6][C:7]1[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=1.[NH:13]1[CH2:18][CH2:17][CH:16]([C:19]2[CH:20]=[C:21]([NH:25][C:26]([CH:28]3[CH2:30][CH2:29]3)=[O:27])[CH:22]=[CH:23][CH:24]=2)[CH2:15][CH2:14]1>>[C:7]1([S:6][CH2:5][CH2:4][CH2:3][CH2:2][N:13]2[CH2:18][CH2:17][CH:16]([C:19]3[CH:20]=[C:21]([NH:25][C:26]([CH:28]4[CH2:29][CH2:30]4)=[O:27])[CH:22]=[CH:23][CH:24]=3)[CH2:15][CH2:14]2)[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=1참가 물질
3
실험 절차
Prepared by Procedure G and Scheme B1 using [(4-chlorobutyl)sulfanyl]benzene and N-[3-(4-piperidinyl)phenyl]cyclopropanecarboxamide: ESMS m/e: 409.5 (M+H)+.
후처리
- customPrepared by Procedure G and Scheme B1
출처 및 근거
- ORD 기록
- ord-62e2972a40b94ba8aaab8958789c8a21
- 출처 데이터셋
- uspto-grants-2004_04
- 특허 번호
- US06727264B1
반응 노트
불러오는 중…